Schett, G

Braun, T; Lepper, J; Ruiz Heiland, G; Hofstetter, W; Siegrist, M; Lezuo, P; Gaestel, M; Rumpler, M; Thaler, R; Klaushofer, K; Distler, JH; Schett, G; Zwerina, J (2013). Mitogen-activated protein kinase 2 regulates physiological and pathological bone turnover. Journal of bone and mineral research, 4(4), pp. 936-947. Hoboken, N.J.: Wiley-Blackwell 10.1002/jbmr.1816

Aringer, M; Burkhardt, H; Burmester, G R; Fischer-Betz, R; Fleck, M; Graninger, W; Hiepe, F; Jacobi, A M; Kötter, I; Lakomek, H J; Lorenz, H M; Manger, B; Schett, G; Schmidt, R E; Schneider, M; Schulze-Koops, H; Smolen, J S; Specker, C; Stoll, T; Strangfeld, A; ... (2012). Current state of evidence on 'off-label' therapeutic options for systemic lupus erythematosus, including biological immunosuppressive agents, in Germany, Austria and Switzerland--a consensus report. Lupus, 21(4), pp. 386-401. London: Sage 10.1177/0961203311426569

Ruiz-Heiland, G; Horn, A; Zerr, P; Hofstetter, W; Baum, W; Stock, M; Distler, JH; Nimmerjahn, F; Schett, G; Zwerina, J (2012). Blockade of the hedgehog pathway inhibits osteophyte formation in arthritis. Annals of the rheumatic diseases, 3(3), pp. 400-407. London: BMJ Publishing Group 10.1136/ard.2010.148262

Meier, FM; Frommer, KW; Dinser, R; Walker, UA; Czirjak, L; Denton, CP; Allanore, Y; Distler, O; Riemekasten, G; Valentini, G; Müller-Ladner, U; Matucci-Cerinic, M; Guiducci, S; Tyndall, A; Lapadula, G; Iannone, F; Becvar, R; Sierakowsky, S; Kowal-Bielecka, O; Cutolo, M; ... (2012). Update on the profile of the EUSTAR cohort: an analysis of the EULAR Scleroderma Trials and Research group database. Annals of the rheumatic diseases, 71(8), pp. 1355-1360. London: BMJ Publishing Group 10.1136/annrheumdis-2011-200742